Biotech Lock-Up Expiration Hell Portfolio

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Biotech Lock-Up Expiration Hell Portfolio

An SI Board Since May 2001

Posts	SubjectMarks	Bans
1005	42	0

Emcee: tuck	Type: Unmoderated

Introduction Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
855	Add Anadys Pharmaceuticals. ANDS. SAN DIEGO--(BUSINESS WIRE)--Nov. 17, 2003--A	keokalani'nui	-	11/17/2003
854	Tuck, On the yahoo GNVC thread, poor grad student has posted some interesting ab	Extra Pale	-	11/17/2003
853	>>GAITHERSBURG, Md., Nov. 17 /PRNewswire-FirstCall/ -- GenVec, Inc. (Nasda	tuck	-	11/17/2003
852	They are making some changes to their "corporate focus", and plannin	Jibacoa	-	11/14/2003
851	I don't know what's juicing LSBC's ride; I concluded they were heade	tuck	-	11/13/2003
850	Tuck, also an article in Washington Post about "mending broken hearts"	Extra Pale	-	11/6/2003
849	BLUE HP hasn't owned GNVC in a while, but the manager's Mom still does	tuck	-	11/6/2003
848	Make it two: biz.yahoo.com Reuters Drug company NitroMed prices IPO at $11 a s	hmpa	-	11/5/2003
847	Another one crawls out the window: >>NEW YORK, Nov 5 (Reuters) - Drug fir	tuck	-	11/5/2003
846	LSBC is now trading at a 52wks. H <g> Message 19467849 Bernard	Jibacoa	-	11/5/2003
845	Add CancerVax. CNVX.	keokalani'nui	-	10/30/2003
844	For those following at home. Here are the symbols of recent and imminent BT IPO	keokalani'nui	-	10/29/2003
843	Renovis S-1a. RNVS. <i>We are a biopharmaceutical company developing dru	keokalani'nui	-	10/29/2003
842	Xcyte S-1. XCYT. <i>We are a biotechnology company developing a new clas	keokalani'nui	-	10/29/2003
841	Would be interested in following Biovitrum's fortunes. Not sure I'll se	keokalani'nui	-	10/28/2003
840	<i>tipped to be one of the first out of the door...</i> STOCKHOLM,	nigel bates	-	10/28/2003
839	UPDATE - Dynavax seeks to raise $90 million in IPO WASHINGTON, Oct 24 (Reuters)	nigel bates	-	10/27/2003
838	The news on LSBC came somewhat late today, but the stock is up more than 9% afte	Jibacoa	-	10/21/2003
837	GTx eyes Nasdaq debut GTx plans to trade on the Nasdaq under the symbol "G	keokalani'nui	-	10/21/2003
836	Ouch: >>>>CHAPEL HILL, N.C. & SAN DIEGO--(BUSINESS WIRE)--Oct.	tuck	-	10/20/2003
835	Advancis Pharmaceuticals Corp Starting off slow. IPO prices at $10, below the 1	michael_f_murphy	-	10/16/2003
834	One more... WASHINGTON, Oct 15 (Reuters) - Biopharmaceutical company GTX Inx.,	nigel bates	-	10/15/2003
833	OT: "A" certainly seems to be the most popular beginning letter for t	The Dodgy Ticker	-	10/13/2003
832	European biotechs prepare to follow U.S. IPO rush Monday October 13, 11:36 am ET	keokalani'nui	-	10/13/2003
831	The following med/drug companies have filed s-1's with an intent to go publi	keokalani'nui	-	10/13/2003

Go to reply# or date (mm/dd/yy):